Somatic DNA hypomethylation in H. Pylori-Associated high-risk gastritis and gastric cancer: Enhanced somatic hypomethylation associates with advanced stage cancer

Clinical and Translational Gastroenterology

Volumn 6, Issue 4, 2015, Pages

  Leodolter, Andreas ^a,b   Alonso, Sergio ^a,c   González, Beatriz ^c   Ebert, Matthias P ^d   Vieth, Michael ^e   Röcken, Christoph ^f   Wex, Thomas ^g   Peitz, Ullrich ^g   Malfertheiner, Peter ^g   Perucho, Manuel ^a,c,h  

^a BURNHAM INSTITUTE   (United States)

^b Ev Hospital   (Germany)

^c Institute of Predictive and Personalized Medicine of Cancer IMPPC   (Spain)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e INSTITUTE OF PATHOLOGY   (Germany)

^f UNIVERSITY OF KIEL   (Germany)

^g OTTO VON GUERICKE UNIVERSITY   (Germany)

^h INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; BACTERIAL CLEARANCE; CANCER PROGNOSIS; CANCER STAGING; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; FEMALE; GASTRIC MUCOSA; GASTRITIS; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HIGH RISK GASTRITIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH BIOPSY; STOMACH CANCER; TUMOR INVASION; VERY ELDERLY;

EID: 84989339562     PISSN: None     EISSN: 2155384X     Source Type: Journal    
DOI: 10.1038/ctg.2015.14     Document Type: Article

References (49)

1. Ferlay J, Shin H, Bray F et al. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10 [Internet]. International Agency for Research on Cancer: Lyon, France, 2010.
2. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349: 1498-1504.
3. Ekstrom AM, Held M, Hansson LE et al. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology 2001; 121: 784-791.
4. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001; 49: 347-353.
5. Uemura N, Okamoto S, Yamamoto S et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-789.
6. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992; 52: 6735-6740.
7. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994; 61: 1-241.
8. Ehrlich M, Gama-Sosa MA, Huang LH et al. Amount and distribution of 5-methylcytosine in human DNA from different types of tissues of cells. Nucleic Acids Res 1982; 10: 2709-2721.
9. Heyn H, Li N, Ferreira HJ et al. Distinct DNA methylomes of newborns and centenarians. Proc Natl Acad Sci U S A 2012; 109: 10522-10527.
10. Smith MR, Liu YL, Matthews NT et al. Phospholipase C-gamma 1 can induce DNA synthesis by a mechanism independent of its lipase activity. Proc Natl Acad Sci U S A 1994; 91: 6554-6558.
11. Hoal-van Helden EG, van Helden PD. Age-related methylation changes in DNA may reflect the proliferative potential of organs. Mutat Res 1989; 219: 263-266.
12. Ehrlich M. DNA methylation in cancer: too much, but also too little. Oncogene 2002; 21: 5400-5413.
13. Rodriguez J, Frigola J, Vendrell E et al. Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers. Cancer Res 2006; 66: 8462-9468.
14. Chen RZ, Pettersson U, Beard C et al. DNA hypomethylation leads to elevated mutation rates. Nature 1998; 395: 89-93.
15. Eden A, Gaudet F, Waghmare A et al. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 2003; 300: 455.
16. Gaudet F, Hodgson JG, Eden A et al. Induction of tumors in mice by genomic hypomethylation. Science 2003; 300: 489-492.
17. Diala ES, Hoffman RM. Hypomethylation of HeLa cell DNA and the absence of 5-methylcytosine in SV40 and adenovirus (type 2) DNA: analysis by HPLC. Biochem Biophys Res Commun 1982; 107: 19-26.
18. Feinberg AP, Tycko B. The history of cancer epigenetics. Nat Rev Cancer 2004; 4: 143-153.
19. Park JH, Park J, Choi JK et al. Identification of DNA methylation changes associated with human gastric cancer. BMC Med Genomics 2011; 4: 82.
20. Yoshida T, Yamashita S, Takamura-Enya T et al. Alu and Satalpha hypomethylation in Helicobacter pylori-infected gastric mucosae. Int J Cancer 2011; 128: 33-39.
21. Suzuki K, Suzuki I, Leodolter A et al. Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. Cancer Cell 2006; 9: 199-207.
22. Shin CM, Kim N, Lee HS et al. Changes in aberrant DNA methylation after helicobacter pylori eradication: A long-term follow-up study. Int J Cancer 2013; 133: 2034-2042.
23. Shin CM, Kim N, Park JH et al. Prediction of the risk for gastric cancer using candidate methylation markers in the non-neoplastic gastric mucosae. J Pathol 2012; 226: 654-665.
24. Cheng AS, Li MS, Kang W et al. Helicobacter pylori causes epigenetic dysregulation of FOXD3 to promote gastric carcinogenesis. Gastroenterology 2013; 144: 122-133.
25. Yoshida T, Kato J, Maekita T et al. Altered mucosal DNA methylation in parallel with highly active Helicobacter pylori-related gastritis. Gastric Cancer 2013; 16: 488-497.
26. Perri F, Cotugno R, Piepoli A et al. Aberrant DNA methylation in non-neoplastic gastric mucosa of H. Pylori infected patients and effect of eradication. Am J Gastroenterol 2007; 102: 1361-1371.
27. Yuasa Y, Nagasaki H, Oze I et al. Insulin-like growth factor 2 hypomethylation of blood leukocyte DNA is associated with gastric cancer risk. Int J Cancer 2012; 131: 2596-2603.
28. Hur K, Han TS, Jung EJ et al. Up-regulated expression of sulfatases (SULF1 and SULF2) as prognostic and metastasis predictive markers in human gastric cancer. J Pathol 2012; 228: 88-98.
29. Bae JM, Shin SH, Kwon HJ et al. ALU and LINE-1 hypomethylations in multistep gastric carcinogenesis and their prognostic implications. Int J Cancer 2012; 131: 1323-1331.
30. Yamamoto E, Toyota M, Suzuki H et al. LINE-1 hypomethylation is associated with increased CpG island methylation in Helicobacter pylori-related enlarged-fold gastritis. Cancer Epidemiol Biomarkers Prev 2008; 17: 2555-2564.
31. Saito M, Suzuki K, Maeda T et al. The accumulation of DNA demethylation in Sat alpha in normal gastric tissues with Helicobacter pylori infection renders susceptibility to gastric cancer in some individuals. Oncol Rep 2012; 27: 1717-1725.
32. Dixon MF, Genta RM, Yardley JH et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-1181.
33. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013; 310: 2191-2194.
34. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning: a laboratory manual. Cold Spring Harbor: New York, 1982.
35. De Smet C, De Backer O, Faraoni I et al. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc Natl Acad Sci U S A 1996; 93: 7149-7153.
36. R Development Core Team R: A language and environment for statistical computing. R Foundation for Statistical Computing: Vienna, Austria, 2009.
37. Miller RG Simultaneous Statistical Inference. New York Heidelberg Springer: Berlin, 1981.
38. Kang GH, Shim YH, Jung HY et al. CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res 2001; 61: 2847-2851.
39. Compare D, Rocco A, Liguori E et al. Global DNA hypomethylation is an early event in Helicobacter pylori-related gastric carcinogenesis. J Clin Pathol 2011; 64: 677-682.
40. To KF, Leung WK, Lee TL et al. Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer. Int J Cancer 2002; 102: 623-628.
41. Waki T, Tamura G, Tsuchiya T et al. Promoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epithelia. Am J Pathol 2002; 161: 399-403.
42. Wong BC, Lam SK, Wong WM et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004; 291: 187-194.
43. Cravo M, Pinto R, Fidalgo P et al. Global DNA hypomethylation occurs in the early stages of intestinal type gastric carcinoma. Gut 1996; 39: 434-438.
44. Weaver BA, Silk AD, Montagna C et al. Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell 2007; 11: 25-36.
45. Ushijima T, Hattori N. Molecular pathways: involvement of Helicobacter pylori-triggered inflammation in the formation of an epigenetic field defect, and its usefulness as cancer risk and exposure markers. Clin Cancer Res 2012; 18: 923-929.
46. Hmadcha A, Bedoya FJ, Sobrino F et al. Methylation-dependent gene silencing induced by interleukin 1beta via nitric oxide production. J Exp Med 1999; 190: 1595-1604.
47. Chan AO, Lam SK, Wong BC et al. Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut 2003; 52: 502-506.
48. Elinav E, Nowarski R, Thaiss CA et al. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer 2013; 13: 759-771.
49. Fan XG, Kelleher D, Fan XJ et al. Helicobacter pylori increases proliferation of gastric epithelial cells. Gut 1996; 38: 19-22.